SOURCE: Southwestern Medical Solutions, Inc.

August 28, 2006 16:00 ET

Southwestern Medical Solutions to Launch International Products Line

TAMPA, FL -- (MARKET WIRE) -- August 28, 2006 -- Southwestern Medical Solutions, Inc. (PINKSHEETS: SWNM) is pleased to announce that it has entered into the final stages of development and within the next two weeks is poised to launch a lineup of products to be marketed exclusively to the international medical markets. Broadening the Product Line

The Company's product portfolio includes Western Blot confirmatory tests for the Human Immunodeficiency virus (HIV), Human T-cell Leukemia virus (HTLV), and Helicobacter pylori; ELISA tests for Hepatitis E virus (HEV) and HTLV; Rapid screening tests for Hepatitis B virus, Helicobacter pylori, Malaria and sexually transmitted diseases.

Instrumentation for the automation of Western Blot processing and interpretation will be added shortly.

Southwestern Medical is also joint-licensed to offer purified native Hepatitis B surface antigens and antibodies, supplying to major diagnostic corporations.

This lineup follows extensive negotiations with suppliers and packaging firms with current overseas regulatory licensing and will allow SWMS to launch in short order with its own product line through joint marketing.

Richard Powell, Vice President of New Product Development, made the following statement regarding this release: "We are an innovative diagnostic company focused on the development and manufacture of in-vitro diagnostic tests for the detection of infectious diseases in humans, as well as our complete lineup of rapid diagnostic tests. This added lineup will add value to the Company by broadening our ability to serve as a one-stop shop for a wide range of in-vitro diagnostics tests."

Southwestern Medical Solutions Has the Answer

SWMS is committed to build on the strength in immunoassay diagnostics to develop and expand its portfolio of products to meet the need for rapid, accurate and affordable disease diagnosis worldwide. The launch of the international products line, to be made official in the next coming days, will mean the entry into a segment that the company has spent the last 12 months of development toward. Southwestern Medical Solutions management and staff worked tirelessly over the past year to broaden its testing modalities to include diagnostics tests based on urine samples and also now blood analysis which will further enhance its one-stop shop image in the healthcare industry.

The statements made in this press release, which are not historical facts, contain forward-looking statements concerning potential developments affecting the business, prospects, financial conditions and other aspects of the Company to which this release pertains. The actual results of the specific items described in the release, and the company's operations generally, may differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the Company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company's dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The Company disclaims any obligation to update information contained in any forward-looking statement.

Contact Information

  • For Further Information:
    Investor Relations Department
    Phone: 1-866-369-9476
    Corporate Phone: 1-877-576-0936
    Southwestern Medical Solutions, Inc.